Page last updated: 2024-08-16

tibolone and Hot Flashes

tibolone has been researched along with Hot Flashes in 48 studies

Research

Studies (48)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (4.17)18.2507
2000's32 (66.67)29.6817
2010's14 (29.17)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abad, P; Baró, F; Cancelo, MJ; Llaneza, P; Manubens, M; Mendoza, N; Quereda, F; Sánchez-Borrego, R1
Balduzzi, S; Basevi, V; Bassi, C; D'Amico, R; Formoso, G; Maestri, E; Magrini, N; Maltoni, S; Marata, AM; Perrone, E; Wilkinson, J1
Beckmann, MW; Bundred, NJ; Egberts, J; Foidart, JM; Kenemans, P; Kubista, E; Mol-Arts, M; Mulder, R; Sismondi, P; van Os, S; Vassilopoulou-Sellin, R; von Schoultz, B; Yip, CH1
Goodwin, PJ1
Agorastos, T; Bontis, JN; Goulis, DG; Pantazis, K; Vavilis, D; Zafrakas, M1
Faghihzadeh, S; Moghasemi, M; Ziaei, S1
Bai, WP; Chen, SL; Geng, L; Hu, LN; Liu, JL; Wang, SY; Zhang, ZL; Zheng, SR1
Kenemans, P1
Antsaklis, A; Dimitrakakis, C; Keramopoulos, D; Tsigginou, A1
Baber, R; Huang, KE1
Barrett, PH; Brown, SJ; Chan, DC; Hampton, RA; Stuckey, BG; Wagner, JM; Watts, GF1
Lumsden, MA; Sassarini, J1
Kloosterboer, HJ1
Biglia, N; Egberts, J; Kenemans, P; Kimmig, R; Kubista, E; Moggio, G; Mol-Arts, M; Mulder, R; Planellas, J; Sismondi, P1
Bao, W; Bouchard, P; Cheng, RJ; Constantine, G; de Villiers, TJ; Panay, N; Vincendon, P1
Almeida, M; Azevedo, G; Cavalcanti, MA; Martins, R; Morais-Socorro, M; Neto Francisco, P; Rezende, A1
Balduzzi, S; Basevi, V; Bassi, C; D'Amico, R; Formoso, G; Maestri, E; Magrini, N; Maltoni, S; Marata, AM; Perrone, E1
Eyster, KM; Hansen, KA1
Bennink, HJ; Engelen, S; Helmond, FA; Landgren, MB1
Metsä-Heikkilä, M; Ylikorkala, O1
Fogelman, I; Robinson, J; Rymer, J1
Di Carlo, C; Mastrantonio, P; Morelli, M; Nappi, C; Noia, R; Palomba, S; Russo, T; Zullo, F1
Morris, E; Rymer, J3
Bundred, N; Fentiman, IS; Foidart, JM; Helmond, FA; Kroiss, R; Kubista, E; Mol-Arts, M; Rymer, J1
Engelen, S; Helmond, FA; Landgren, MB1
Anderson, GL; Chlebowski, RT1
Chrystyn, H; Elfituri, A; Elmahaishi, M; Sherif, F1
Baber, R; Hickey, M; Kwik, M1
Busiello, A; Carbone, IF; D'Armiento, FP; De Falco, M; Di Lieto, A; Mascolo, M; Pollio, F; Salvatore, G; Staibano, S1
Antoine, C; Carly, B; Liebens, F; Pastijn, A; Rozenberg, S1
Gompel, A; Piette, JC1
Bai, W; Geng, L; Henneicke-von Zepelin, HH; Hu, L; Jiao, C; Liske, E; Liu, J; Wang, S; Zhang, Z; Zheng, S1
Diaby, V; Lachaine, J; Perreault, S1
Franke, HR; Hammar, ML; Nijland, EA; Pornel, B; van de Weijer, P; von Mauw, EM1
Lazovic, G; Marinkovic, J; Radivojevic, U1
Garefalakis, M; Hickey, M1
Christau, S; Garre, K; Hammar, M; Nathorst-Böös, J; Rud, T1
Akkad, A; Al-Azzawi, F; Habiba, M; Mason, T; Wahab, M1
Di Carlo, C; Di Spiezio Sardo, A; Guida, M; Nappi, C; Palomba, S; Tommaselli, GA1
Affinito, P; Di Carlo, C; Nappi, C; Palomba, S; Pellicano, M; Zullo, F1
Berendsen, HH; Kloosterboer, HJ; Weekers, AH1
Cummings, S; Modelska, K1
Malinova, M; Milchev, N; Pekhlivanov, B1
Duursma, SA; Meeuwsen, IB; Samson, MM; Verhaar, HJ1
Baracat, EC; Barbosa, IC; Giordano, MG; Haidar, MA; Marinho, RM; Menegocci, JC; Morais, KM; Tomaz, G; Wehba, S1

Reviews

14 review(s) available for tibolone and Hot Flashes

ArticleYear
Short-term and long-term effects of tibolone in postmenopausal women.
    The Cochrane database of systematic reviews, 2016, Oct-12, Volume: 10

    Topics: Aged; Breast Neoplasms; Dyspareunia; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Postmenopause; Randomized Controlled Trials as Topic; Stroke; Sweating; Uterine Hemorrhage

2016
Updated clinical recommendations for the use of tibolone in Asian women.
    Climacteric : the journal of the International Menopause Society, 2010, Volume: 13, Issue:4

    Topics: Arthralgia; Breast Neoplasms; Cardiovascular Diseases; Contraindications; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Health Knowledge, Attitudes, Practice; Hot Flashes; Humans; Middle Aged; Musculoskeletal Diseases; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Rural Population; Sexual Dysfunctions, Psychological; Sleep Initiation and Maintenance Disorders; Urban Population

2010
Hot flushes: are there effective alternatives to estrogen?
    Menopause international, 2010, Volume: 16, Issue:2

    Topics: Acupuncture Therapy; Amines; Cimicifuga; Clonidine; Cyclohexanecarboxylic Acids; Estrogen Replacement Therapy; Exercise; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Menopause; New Zealand; Norpregnenes; Phytoestrogens; Progesterone; Selective Serotonin Reuptake Inhibitors; Skin; United Kingdom; United States; Vitamin E

2010
Short and long term effects of tibolone in postmenopausal women.
    The Cochrane database of systematic reviews, 2012, Feb-15, Issue:2

    Topics: Aged; Breast Neoplasms; Dyspareunia; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Postmenopause; Stroke; Sweating; Uterine Hemorrhage

2012
Hormone replacement therapy in women with a history of breast cancer.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2002, Volume: 16, Issue:6

    Topics: Breast Neoplasms; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Menopause; Neoplasm Recurrence, Local; Norpregnenes; Quality of Life; Risk Factors; Selective Estrogen Receptor Modulators

2002
Menopausal symptoms.
    Clinical evidence, 2003, Issue:10

    Topics: Clonidine; Estrogens; Female; Hot Flashes; Humans; Menopause; Norpregnenes; Phytoestrogens; Progestins

2003
Menopausal symptoms.
    Clinical evidence, 2004, Issue:11

    Topics: Clonidine; Estrogens; Female; Hot Flashes; Humans; Menopause; Norpregnenes; Phytoestrogens; Progestins

2004
Menopausal symptoms.
    Clinical evidence, 2005, Issue:13

    Topics: Drug Therapy, Combination; Estrogens; Female; Hot Flashes; Humans; Menopause; Norpregnenes; Phytoestrogens; Progestins

2005
Therapy for menopausal symptoms during and after treatment for breast cancer : safety considerations.
    Drug safety, 2005, Volume: 28, Issue:12

    Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Case-Control Studies; Clonidine; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Health Behavior; Hot Flashes; Humans; Menopause; Norpregnenes; Paroxetine; Personal Health Services; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Tamoxifen

2005
Safety of alternative treatments for menopausal symptoms after breast cancer: a qualitative systematic review.
    Climacteric : the journal of the International Menopause Society, 2007, Volume: 10, Issue:1

    Topics: Antidepressive Agents; Breast Neoplasms; Estrogen Receptor Modulators; Female; Histamine H1 Antagonists; Hot Flashes; Humans; Menopause; Norpregnenes

2007
Systemic lupus erythematosus and hormone replacement therapy.
    Menopause international, 2007, Volume: 13, Issue:2

    Topics: Animals; Breast Neoplasms; Contraindications; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Lupus Coagulation Inhibitor; Lupus Erythematosus, Systemic; Norpregnenes; Osteoporosis, Postmenopausal; Progesterone; Progestins; Research Design; Risk Assessment; Thrombosis; Women's Health

2007
Tibolone: the way to beat many a postmenopausal ailments.
    Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:6

    Topics: Breast Neoplasms; Cardiovascular Diseases; Climacteric; Endometrium; Estrogen Receptor Modulators; Estrogens; Female; Hot Flashes; Humans; Menopause; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Randomized Controlled Trials as Topic; Risk Factors; Stroke

2008
Role of androgens, progestins and tibolone in the treatment of menopausal symptoms: a review of the clinical evidence.
    Clinical interventions in aging, 2008, Volume: 3, Issue:1

    Topics: Affect; Androgens; Cognition; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Libido; Menopause; Middle Aged; Norpregnenes; Progestins; Testosterone

2008
Tibolone for postmenopausal women: systematic review of randomized trials.
    The Journal of clinical endocrinology and metabolism, 2002, Volume: 87, Issue:1

    Topics: Adult; Affect; Aged; Aged, 80 and over; Double-Blind Method; Female; Hot Flashes; Humans; Lipids; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Randomized Controlled Trials as Topic; Sweating

2002

Trials

22 trial(s) available for tibolone and Hot Flashes

ArticleYear
Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial.
    The Lancet. Oncology, 2009, Volume: 10, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Double-Blind Method; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Osteoporosis, Postmenopausal; Vasomotor System

2009
Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.
    Climacteric : the journal of the International Menopause Society, 2010, Volume: 13, Issue:2

    Topics: Cluster Analysis; Drug Therapy, Combination; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Libido; Middle Aged; Norpregnenes; Orgasm; Postmenopause; Prospective Studies; Sexual Behavior; Sexual Dysfunction, Physiological; Testosterone; Treatment Outcome

2010
[Efficacy and safety of remifemin compared to tibolone for controlling of perimenopausal symptoms].
    Zhonghua fu chan ke za zhi, 2009, Volume: 44, Issue:8

    Topics: Administration, Oral; Adult; Cimicifuga; Double-Blind Method; Endometrium; Female; Hot Flashes; Humans; Middle Aged; Nervous System Diseases; Norpregnenes; Perimenopause; Phytotherapy; Plant Extracts; Uterine Hemorrhage

2009
What have we really learned from 'LIBERATE' trial?
    Maturitas, 2010, Volume: 66, Issue:1

    Topics: Breast Neoplasms; Estrogen Receptor Modulators; Female; Hot Flashes; Humans; Menopause; Neoplasm Recurrence, Local; Norpregnenes

2010
The effect of fenofibrate on HDL cholesterol and HDL particle concentration in postmenopausal women on tibolone therapy.
    Clinical endocrinology, 2010, Volume: 73, Issue:4

    Topics: Aged; Apolipoprotein A-II; Cholesterol, HDL; Cross-Over Studies; Estrogen Receptor Modulators; Female; Fenofibrate; Hot Flashes; Humans; Hypolipidemic Agents; Lipoproteins, HDL; Middle Aged; Norpregnenes; Postmenopause

2010
Effects of tibolone on climacteric symptoms and quality of life in breast cancer patients--data from LIBERATE trial.
    Maturitas, 2011, Volume: 70, Issue:4

    Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Atrophic Vaginitis; Breast Neoplasms; Climacteric; Contraindications; Estrogen Receptor Modulators; Female; Hot Flashes; Humans; Intention to Treat Analysis; Longitudinal Studies; Middle Aged; Norpregnenes; Postmenopause; Quality of Life; Surveys and Questionnaires; Tamoxifen

2011
Randomized placebo- and active-controlled study of desvenlafaxine for menopausal vasomotor symptoms.
    Climacteric : the journal of the International Menopause Society, 2012, Volume: 15, Issue:1

    Topics: Adult; Aged; Cyclohexanols; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Estrogen Receptor Modulators; Female; Follicle Stimulating Hormone; Hot Flashes; Humans; Menopause; Middle Aged; Neurotransmitter Uptake Inhibitors; Norpregnenes; Treatment Outcome; Vasomotor System

2012
Safety and efficacy of tibolone and menopausal transition: a randomized, double-blind placebo-controlled trial.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2012, Volume: 28, Issue:6

    Topics: Administration, Oral; Adult; Double-Blind Method; Endometrium; Estrogen Receptor Modulators; Female; Hot Flashes; Humans; Menopause; Middle Aged; Norpregnenes; Organ Size; Placebos; Treatment Outcome; Ultrasonography

2012
Dose-response analysis of effects of tibolone on climacteric symptoms.
    BJOG : an international journal of obstetrics and gynaecology, 2002, Volume: 109, Issue:10

    Topics: Adult; Climacteric; Dose-Response Relationship, Drug; Double-Blind Method; Estrogen Receptor Modulators; Female; Hot Flashes; Humans; Middle Aged; Norpregnenes; Sweating; Uterine Hemorrhage

2002
Effect of tibolone on breast symptoms resulting from postmenopausal hormone replacement therapy.
    Maturitas, 2003, Aug-20, Volume: 45, Issue:4

    Topics: Breast; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Incidence; Middle Aged; Norpregnenes; Pain; Pain Measurement; Postmenopause; Prospective Studies; Surveys and Questionnaires

2003
The effect of tibolone in postmenopausal women receiving tamoxifen after surgery for breast cancer: a randomised, double-blind, placebo-controlled trial.
    BJOG : an international journal of obstetrics and gynaecology, 2005, Volume: 112, Issue:2

    Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Chemotherapy, Adjuvant; Double-Blind Method; Endometrium; Estrogen Antagonists; Estrogen Receptor Modulators; Female; Hot Flashes; Humans; Hyperhidrosis; Lipids; Mammography; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Pilot Projects; Postmenopause; Tamoxifen

2005
Tibolone relieves climacteric symptoms in highly symptomatic women with at least seven hot flushes and sweats per day.
    Maturitas, 2005, Mar-14, Volume: 50, Issue:3

    Topics: Climacteric; Dose-Response Relationship, Drug; Double-Blind Method; Estrogen Receptor Modulators; Europe; Female; Hot Flashes; Humans; Middle Aged; Norpregnenes; Sweating; Treatment Outcome; Uterine Hemorrhage

2005
Two hormone replacement therapy (HRT) regimens for middle-eastern postmenopausal women.
    Maturitas, 2005, Sep-16, Volume: 52, Issue:1

    Topics: Administration, Oral; Adult; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Libya; Longitudinal Studies; Middle Aged; Norpregnenes; Postmenopause; Prospective Studies; Severity of Illness Index; Treatment Outcome; White People

2005
Preoperative treatment of uterine leiomyomas: clinical findings and expression of transforming growth factor-beta3 and connective tissue growth factor.
    Journal of the Society for Gynecologic Investigation, 2006, Volume: 13, Issue:4

    Topics: Adult; Antineoplastic Agents, Hormonal; Bone Density; Connective Tissue Growth Factor; Drug Therapy, Combination; Female; Hemoglobins; Hot Flashes; Humans; Immediate-Early Proteins; Immunohistochemistry; Injections, Subcutaneous; Intercellular Signaling Peptides and Proteins; Iron; Leiomyoma; Leuprolide; Myometrium; Neoadjuvant Therapy; Norpregnenes; Transforming Growth Factor beta; Transforming Growth Factor beta3; Uterine Neoplasms

2006
Efficacy and tolerability of a medicinal product containing an isopropanolic black cohosh extract in Chinese women with menopausal symptoms: a randomized, double blind, parallel-controlled study versus tibolone.
    Maturitas, 2007, Sep-20, Volume: 58, Issue:1

    Topics: Adult; Asian People; China; Cimicifuga; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blind Method; Estrogen Receptor Modulators; Female; Hot Flashes; Humans; Menopause; Metrorrhagia; Middle Aged; Norpregnenes; Odds Ratio; Phytoestrogens; Phytotherapy; Plant Extracts; Statistics, Nonparametric

2007
Tibolone and low-dose continuous combined hormone treatment: vaginal bleeding pattern, efficacy and tolerability.
    BJOG : an international journal of obstetrics and gynaecology, 2007, Volume: 114, Issue:12

    Topics: Aged; Contraceptives, Oral, Synthetic; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Hot Flashes; Humans; Metrorrhagia; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes

2007
A double-blind, randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms.
    British journal of obstetrics and gynaecology, 1998, Volume: 105, Issue:8

    Topics: Anabolic Agents; Double-Blind Method; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Menopause; Middle Aged; Norethindrone; Norpregnenes; Postmenopause; Progesterone Congeners; Sexual Behavior; Sweating; Uterine Hemorrhage; Vaginal Diseases

1998
Continuous combined hormone replacement therapy compared with tibolone.
    Obstetrics and gynecology, 1999, Volume: 93, Issue:2

    Topics: Climacteric; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Lipoproteins; Menstruation; Middle Aged; Minor Histocompatibility Loci; Norethindrone; Norpregnenes; Progesterone Congeners

1999
Use of leuprolide acetate plus tibolone in the treatment of severe premenstrual syndrome.
    Fertility and sterility, 2001, Volume: 75, Issue:2

    Topics: Adult; Anabolic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Hot Flashes; Humans; Leuprolide; Norpregnenes; Placebos; Premenstrual Syndrome; Prospective Studies

2001
Effectiveness of short-term administration of tibolone plus gonadotropin-releasing hormone analogue on the surgical outcome of laparoscopic myomectomy.
    Fertility and sterility, 2001, Volume: 75, Issue:2

    Topics: Adult; Combined Modality Therapy; Female; Gonadotropin-Releasing Hormone; Hot Flashes; Humans; Iron; Laparoscopy; Leiomyoma; Leuprolide; Norpregnenes; Placebos; Prospective Studies; Treatment Outcome; Uterine Neoplasms

2001
The influence of tibolone on quality of life in postmenopausal women.
    Maturitas, 2002, Jan-30, Volume: 41, Issue:1

    Topics: Anabolic Agents; Double-Blind Method; Female; Hot Flashes; Humans; Menopause; Middle Aged; Norpregnenes; Quality of Life; Surveys and Questionnaires; Treatment Outcome

2002
A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability.
    Climacteric : the journal of the International Menopause Society, 2002, Volume: 5, Issue:1

    Topics: Aged; Animals; Coitus; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Female Urogenital Diseases; Horses; Hot Flashes; Humans; Lipids; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Uterine Hemorrhage; Weight Gain

2002

Other Studies

12 other study(ies) available for tibolone and Hot Flashes

ArticleYear
Spanish Menopause Society position statement: use of tibolone in postmenopausal women.
    Menopause (New York, N.Y.), 2013, Volume: 20, Issue:7

    Topics: Aged; Bone Density; Cardiovascular Diseases; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Quality of Life; Randomized Controlled Trials as Topic; Sexual Dysfunction, Physiological; Societies, Medical; Spain

2013
Tibolone: the risk is too high.
    The Lancet. Oncology, 2009, Volume: 10, Issue:2

    Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Clinical Trials as Topic; Estrogen Replacement Therapy; Hot Flashes; Humans; Menopause; Neoplasm Recurrence, Local; Norpregnenes; Risk

2009
Hormone therapy for postmenopausal breast cancer survivors: a survey among obstetrician-gynaecologists.
    European journal of gynaecological oncology, 2009, Volume: 30, Issue:1

    Topics: Breast Neoplasms; Data Collection; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Greece; Gynecology; Hot Flashes; Humans; Norpregnenes; Osteoporosis, Postmenopausal; Practice Patterns, Physicians'

2009
Tibolone revisited: still a good treatment option for healthy, early postmenopausal women.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2010, Volume: 26, Issue:4

    Topics: Age Factors; Breast Neoplasms; Contraindications; Estrogen Receptor Modulators; Female; Heart Diseases; Hot Flashes; Humans; Norpregnenes; Patient Selection; Postmenopause; Risk Factors; Stroke

2010
Historical milestones in the development of tibolone (Livial®).
    Climacteric : the journal of the International Menopause Society, 2011, Volume: 14, Issue:6

    Topics: Estrogen Receptor Modulators; Female; History, 20th Century; History, 21st Century; Hot Flashes; Humans; Norpregnenes; Osteoporosis, Postmenopausal

2011
What happened to WHI: menopausal hormonal therapy in 2012.
    Clinical obstetrics and gynecology, 2012, Volume: 55, Issue:3

    Topics: Atrophy; Breast Neoplasms; Endometrial Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Hot Flashes; Humans; Menopause; Middle Aged; Norpregnenes; Patient Selection; Raloxifene Hydrochloride; Vagina

2012
Ten years of treatment with tibolone 2.5 mg daily: effects on bone loss in postmenopausal women.
    Climacteric : the journal of the International Menopause Society, 2002, Volume: 5, Issue:4

    Topics: Alkaline Phosphatase; Bone Density; Calcium; Case-Control Studies; Creatinine; Dose-Response Relationship, Drug; Drug Administration Schedule; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Femur Neck; Hot Flashes; Humans; Lumbar Vertebrae; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Prospective Studies; Time Factors; United Kingdom; Vagina

2002
Hot flashes. A closer look at causes and remedies.
    Mayo Clinic women's healthsource, 2003, Volume: 7, Issue:4

    Topics: Acetates; Amines; Antidepressive Agents; Body Temperature Regulation; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Hypothalamus; Norpregnenes

2003
Progestins and recurrence in breast cancer survivors.
    Journal of the National Cancer Institute, 2005, Apr-06, Volume: 97, Issue:7

    Topics: Breast Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Europe; Female; Hot Flashes; Humans; Menopause; Neoplasm Recurrence, Local; Norpregnenes; Progestins; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Survivors; Treatment Outcome

2005
Economic impact of Tibolone compared with Continuous-Combined Hormone Replacement Therapy in the management of climacteric symptoms in postmenopausal women.
    Maturitas, 2007, Oct-20, Volume: 58, Issue:2

    Topics: Canada; Cost-Benefit Analysis; Drug Administration Schedule; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Markov Chains; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Quality-Adjusted Life Years

2007
Effect of tibolone and raloxifene on the tail temperature of oestrogen-deficient rats.
    European journal of pharmacology, 2001, May-04, Volume: 419, Issue:1

    Topics: Adrenergic alpha-Agonists; Anabolic Agents; Animals; Body Temperature; Clonidine; Dose-Response Relationship, Drug; Estradiol; Estrogens; Female; Hot Flashes; Humans; Motor Activity; Norpregnenes; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Wistar; Selective Estrogen Receptor Modulators; Tail

2001
[Our experience in the treatment of climacteric complaints with Livial (Organon)].
    Akusherstvo i ginekologiia, 2001, Volume: 40, Issue:4

    Topics: Anabolic Agents; Climacteric; Female; Hot Flashes; Humans; Nausea; Norpregnenes; Treatment Outcome; Uterine Hemorrhage

2001